Remodeling after stroke.
Zlokovic
Berislav V
BV
D000818:Animals; D001253:Astrocytes / Q000201:enzymology / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002545:Brain Ischemia / Q000378:metabolism* / Q000473:pathology; D002540:Cerebral Cortex / Q000201:enzymology / Q000473:pathology; D004195:Disease Models, Animal; D006801:Humans; D007276:Injections, Intraventricular; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D008954:Models, Biological; D009474:Neurons / Q000201:enzymology / Q000378:metabolism; D051381:Rats; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000378:metabolism; D020521:Stroke / Q000473:pathology*; D013997:Time Factors; D019714:Tissue Inhibitor of Metalloproteinases / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A / Q000008:administration & dosage / Q000235:genetics / Q000378:metabolism
D015415:Biomarkers; D011994:Recombinant Proteins; D019714:Tissue Inhibitor of Metalloproteinases; D042461:Vascular Endothelial Growth Factor A; D020780:Matrix Metalloproteinase 9